Quanterix (NasdaqGM:QTRX) Q3 2025 Earnings Call November 10, 2025 04:30 PM ET Speaker0Hello and thank you for standing by. My name is Tiffany and I will be your conference operator today. At this time I would like to welcome everyone to the Quanterix Corporation Q3 2025 earnings call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question and answer session. If you would like to ask a question during that time, simply press Star then the num ...

Inovio Pharmaceuticals (NasdaqCM:INO) Q3 2025 Earnings Call November 10, 2025 04:30 PM ET Speaker3Good afternoon, ladies and gentlemen, and welcome to the Inovio Q3 2025 Financial Results Conference Call. At this time, all lines are in listen-only mode. Following the presentation, we will conduct a question-and-answer session. If at any time during this call you require immediate assistance, please press star zero for the operator. This call is being recorded on Monday, November 10, 2025. I would now like t ...

Guardian Pharmacy Services (NYSE:GRDN) Q3 2025 Earnings Call November 10, 2025 04:30 PM ET Speaker1Good day, everyone, and welcome to Guardian Pharmacy Services' third quarter earnings call. At this time, all participants are on a listen-only mode. Later, you will have the opportunity to ask questions during the question-and-answer session. I will now hand the call over to Ashley Stockton.Speaker2Good afternoon. Thank you for participating in today's conference call. This is Ashley Stockton, Senior Director ...

iHeartMedia (NasdaqGS:IHRT) Q3 2025 Earnings Call November 10, 2025 04:30 PM ET Speaker0Good afternoon and welcome to iHeartMedia's Third Quarter 2025 earnings call. All participants are in a listen-only mode. After the speaker's remarks, we will have a question-and-answer session. To ask a question, please press star followed by the number one on your telephone keypad. As a reminder, this conference call is being recorded. I would now like to turn the call over to Mike McGuinness, Head of Investor Relation ...

Skye Bioscience (NasdaqGM:SKYE) Q3 2025 Earnings Call November 10, 2025 04:30 PM ET Speaker3Ladies and gentlemen, thank you for standing by. My name is Jordan, and I'll be your conference operator today. At this time, I would like to welcome everyone to the Skye Bioscience Q3 2025 financial results and business update call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question-and-answer session. I would now like to turn the conference over ...

Oscar Health (NYSE:OSCR) 2025 Conference November 10, 2025 04:15 PM ET Speaker1All right. Thanks, everyone, for joining us. Here we have Oscar Health, CFO, Scott Blackley, who's joining me on stage. I guess we'll kind of jump in before we talk about the other big things that have happened. We'll start with just your third-quarter results. We obviously kind of saw what happened. I guess on the weekly data, it impacted your third-quarter results. Assuming it remains stable from here on out, given it was off, ...

Liquidia Corp (NasdaqCM:LQDA) 2025 Conference November 10, 2025 04:15 PM ET Company ParticipantsJason Adair - Chief Business OfficerMichael Kaseta - COO and CFOModeratorThis Healthcare Conference, and the next company presenting here today is Liquidia. Really, really excited to have Michael Kaseta, who is the Chief Operating Officer and Chief Financial Officer, and Jason Adair, who is the Chief Business Officer. Thanks, guys, for joining.Michael KasetaAppreciate it.ModeratorExciting times with the story. Ye ...

Q3'25 Investor Presentation For personal use only 10 Nov 2025 U.S. PT | 11 Nov 2025 AEDT Investor Presentation | November 2025 DISCLAIMER These materials and the accompanying oral presentation have been prepared by Life360, Inc. (ARBN 629 412 942) ("Company") on a confidential and non-reliance basis, and may not be reproduced in whole or in part, nor may any of its contents be disclosed, to any other person, without the prior written consent of the Company. These materials are for informational purposes onl ...

NYSE: DHX Q3 2025 Investor Presentation November 10, 2025 Forward looking statements This presenation and oral statements made from time to time by our representatives contain forward- looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. You should not place undue reliance on those statements because they are subject to numerous uncertainties an ...

03-2025 INFESTOR UPDATE Sir Peter Beck, CEO Adam Spice, CFO November 10, 2025 ROCKETLAB Forward Looking Statements This presentation may contain certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of historical facts, contained in this presentation, including statements regarding our expec ...